Norman Ng, Director of Patient Advocacy and Public Affairs at Healthcare Thinkers, shared on LinkedIn:
”China has solid innovation foundations. Amid complex geopolitics for global expansion, three guiding principles stand out:
Do not evade, do not over‑exaggerate, do not misjudge. The industry should shift focus from speed‑and‑scale to trust‑and‑value, building globally‑accepted value frameworks grounded in robust clinical data.
Hong Kong serves as a vital international hub can contribute by:
- Early pipeline tracking for mainland‑developed lung‑cancer drugs
- Collaborating with priority‑review schemes to accelerate local registration
- Conducting international‑standard clinical and HTA assessment, translating Chinese real‑world data into global value evidence
- Acting as two‑way bridge, benefiting patients in both regions and supporting global launch of home‑grown therapies.
We look forward to broader treatment options for lung‑cancer patients.”
Norman Ng was recognized among OncoDaily’s The 100 Most Influential People in Oncology in 2025, highlighting his contributions to the field of oncology.
Nominations for 100 Influential People in Oncology 2026 are now open, recognizing leaders, researchers, clinicians, innovators, advocates, and other individuals making a meaningful impact on oncology and cancer care.
Don’t miss the opportunity to nominate yourself, a colleague, or someone whose contributions deserve to be recognized.
Submit your nomination by September 15: 100 Influential People in Oncology 2026 – Nominations are Open!
Other articles featuring Norman Ng on OncoDaily.